MX350125B - Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo. - Google Patents

Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo.

Info

Publication number
MX350125B
MX350125B MX2015001670A MX2015001670A MX350125B MX 350125 B MX350125 B MX 350125B MX 2015001670 A MX2015001670 A MX 2015001670A MX 2015001670 A MX2015001670 A MX 2015001670A MX 350125 B MX350125 B MX 350125B
Authority
MX
Mexico
Prior art keywords
eprotirome
hair
prevention
compositions
treatment
Prior art date
Application number
MX2015001670A
Other languages
English (en)
Other versions
MX2015001670A (es
Inventor
Michael Soeberdt
Christoph Abels
Ulrich Knie
Original Assignee
Dr August Wolff Gmbh & Co Kg Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr August Wolff Gmbh & Co Kg Arzneimittel filed Critical Dr August Wolff Gmbh & Co Kg Arzneimittel
Publication of MX2015001670A publication Critical patent/MX2015001670A/es
Publication of MX350125B publication Critical patent/MX350125B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención proporciona métodos para prevenir y/o tratar trastornos del cabello, en particular para prevenir y/o tratar cabello canoso y pérdida del cabello, incluyendo detener y/o revertir la pérdida del cabello y promover el crecimiento del cabello, en un mamífero, así como composiciones farmacéuticas que contienen eprotirom como ingrediente activo.
MX2015001670A 2012-08-06 2013-08-05 Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo. MX350125B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679990P 2012-08-06 2012-08-06
EP12179384.8A EP2695611B1 (en) 2012-08-06 2012-08-06 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
PCT/EP2013/066409 WO2014023698A1 (en) 2012-08-06 2013-08-05 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof

Publications (2)

Publication Number Publication Date
MX2015001670A MX2015001670A (es) 2015-04-10
MX350125B true MX350125B (es) 2017-08-28

Family

ID=46963380

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001670A MX350125B (es) 2012-08-06 2013-08-05 Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo.

Country Status (16)

Country Link
US (1) US20150182482A1 (es)
EP (1) EP2695611B1 (es)
JP (1) JP6125012B2 (es)
KR (1) KR20150039824A (es)
CN (1) CN104717964A (es)
AU (1) AU2013301601B2 (es)
BR (1) BR112015002540A2 (es)
CA (1) CA2879847C (es)
DK (1) DK2695611T3 (es)
ES (1) ES2528392T3 (es)
HK (1) HK1206598A1 (es)
MX (1) MX350125B (es)
PL (1) PL2695611T3 (es)
RU (1) RU2015107846A (es)
SG (1) SG11201500838UA (es)
WO (1) WO2014023698A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55890A (fr) 2019-05-08 2022-03-16 Aligos Therapeutics Inc Modulateurs de thr-beta et leurs procédés d'utilisation
CN111110600B (zh) * 2019-12-31 2021-08-06 泉后(深圳)信息技术有限公司 一种头皮净化促生发组合物及其乳液

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0580550T3 (da) * 1992-07-21 1998-02-02 Ciba Geigy Ag Oxamidsyrederivater som hypercholesterolæmiske midler
WO1996025943A1 (en) 1995-02-23 1996-08-29 Life Medical Sciences, Inc. Compositions and methods for enhancing the growth of hair and restoring hair color
MXPA01012491A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Compuestos de eter biarilico sustituido.
AR018699A1 (es) 1999-06-01 2001-11-28 Procter & Gamble Metodo para el tratamiento de la perdida del cabello el cual comprende administrar una composicion que comprende un compuesto el cual no afecta al corazon
JP2003500431A (ja) 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター 毛髪の損失を治療する方法
MXPA01012495A (es) * 1999-06-01 2003-09-10 Univ Texas Southwestern Med Ct Metodo para tratar la perdida capilar con el uso de derivados de difenilmetano.
CA2374263A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylether derivatives
JP2003500483A (ja) 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ビアリール化合物
AU2001230929B2 (en) * 2000-02-17 2004-09-23 Bristol-Myers Squibb Co. Aniline-derived ligands for the thyroid receptor
BR0109625A (pt) 2000-03-31 2003-04-22 Pfizer Prod Inc cidos malonñmicos e seus derivados como ligandos do receptor da tireóide
DK1262177T3 (da) 2001-05-31 2006-11-20 Pfizer Prod Inc Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
ATE313325T1 (de) 2001-09-26 2006-01-15 Pfizer Prod Inc Indolcaroboxylsäure als thyroidrezeptor-liganden
US6806381B2 (en) 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
WO2003064369A1 (fr) 2002-01-30 2003-08-07 Kissei Pharmaceutical Co., Ltd. Nouveau ligand de recepteur de l'hormone thyroidienne, preparations medicinales le contenant et leur utilisation
US7812299B2 (en) 2005-07-22 2010-10-12 Nikon Corporation Image sensor having two-dimensionally arrayed pixels, focus detecting device using the sensor, and imaging system including the sensor
JP4810151B2 (ja) 2005-07-22 2011-11-09 出光興産株式会社 イネの育苗時期に発生する病害に対する防除剤
GB0606201D0 (en) 2006-03-28 2006-05-10 Karobio Ab Improved crytalline material
AU2007265940A1 (en) 2006-06-28 2008-01-03 Sanwa Kagaku Kenkyusho Co., Ltd. Novel 6-5 System Bicyclic Heterocyclic Derivative And Its Pharmaceutical Utility
GB0724478D0 (en) 2007-12-14 2008-01-30 Karobio Ab Pharmaceutical compositions
GB0725214D0 (en) 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2009155261A (ja) 2007-12-26 2009-07-16 Sanwa Kagaku Kenkyusho Co Ltd 新規インドール誘導体及びその医薬用途
EP2609910A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Formulations of eprotirome

Also Published As

Publication number Publication date
MX2015001670A (es) 2015-04-10
AU2013301601A1 (en) 2015-02-05
CA2879847A1 (en) 2014-02-13
HK1206598A1 (en) 2016-01-15
US20150182482A1 (en) 2015-07-02
RU2015107846A (ru) 2016-09-27
JP6125012B2 (ja) 2017-05-10
EP2695611A1 (en) 2014-02-12
PL2695611T3 (pl) 2015-03-31
CA2879847C (en) 2017-10-03
BR112015002540A2 (pt) 2017-12-12
AU2013301601B2 (en) 2016-09-01
WO2014023698A1 (en) 2014-02-13
JP2015524458A (ja) 2015-08-24
SG11201500838UA (en) 2015-03-30
ES2528392T3 (es) 2015-02-09
DK2695611T3 (en) 2015-01-05
CN104717964A (zh) 2015-06-17
KR20150039824A (ko) 2015-04-13
EP2695611B1 (en) 2014-10-01

Similar Documents

Publication Publication Date Title
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
MX2015016983A (es) Moduladores del transporte nuclear y usos de los mismos.
MX365835B (es) Uso de akkermansia para tratar trastornos metabolicos.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
NZ702663A (en) Nuclear transport modulators and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
EA033374B9 (ru) Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
NZ729252A (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
HK1215682A1 (zh) 用於治療或預防齲齒的組合物、用途和方法
EP2886112A4 (en) COMPOSITION CONTAINING AS ACTIVE INGREDIENT OF S-ALLYL-L-CYSTEINE FOR PREVENTING OR TREATING OCULAR DISEASES, AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME
MX350125B (es) Eprotirom para uso en la prevención y/o tratamiento de trastornos del cabello y composiciones del mismo.
WO2013038200A3 (en) Neurodevelopmental disorders
EP3053601A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER CONTAINING THE CYB5R3 GENE OR PROTEIN AS AN ACTIVE SUBSTANCE
WO2012170664A3 (en) Methods of cancer treatment and prevention through the modulation of sirt4 activity
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
WO2014082738A8 (en) Heteroquinoline-3-carboxamides as kcnq2/3 modulators

Legal Events

Date Code Title Description
FG Grant or registration